oxophenylarsine has been researched along with melatonin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cui, ZG; Feng, QW; Inadera, H; Li, JL; Li, ML; Li, YL; Muhammad, JS; Sun, L; Zakki, SA | 1 |
1 other study(ies) available for oxophenylarsine and melatonin
Article | Year |
---|---|
Melatonin triggers the anticancer potential of phenylarsine oxide via induction of apoptosis through ROS generation and JNK activation.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Arsenicals; Cell Line, Tumor; Enzyme Activation; Enzyme Activators; Humans; MAP Kinase Kinase 4; Melatonin; Neoplasms; Reactive Oxygen Species | 2020 |